BARDX
Price
$8.11
Change
-$0.05 (-0.61%)
Updated
May 8 closing price
Net Assets
222.9M
VGRLX
Price
$26.21
Change
-$0.28 (-1.06%)
Updated
May 8 closing price
Net Assets
3.57B
Ad is loading...

BARDX vs VGRLX

Header iconBARDX vs VGRLX Comparison
Open Charts BARDX vs VGRLXBanner chart's image
iShares Developed Real Estate Idx Inv A
Price$8.11
Change-$0.05 (-0.61%)
VolumeN/A
Net Assets222.9M
Vanguard Global ex-US Real Est Idx Adm
Price$26.21
Change-$0.28 (-1.06%)
VolumeN/A
Net Assets3.57B
BARDX vs VGRLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BARDX vs. VGRLX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BARDX is a Buy and VGRLX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VGRLX has more cash in the bank: 3.57B vs. BARDX (223M). VGRLX pays higher dividends than BARDX: VGRLX (4.74) vs BARDX (2.61). BARDX was incepted earlier than VGRLX: BARDX (10 years) vs VGRLX (14 years). BARDX (0.60) is less costly to investors than VGRLX (0.12). BARDX is a more actively managed with annual turnover of: 20.00 vs. VGRLX (7.00). BARDX has a lower initial minimum investment than VGRLX: BARDX (1000) vs VGRLX (3000). VGRLX annual gain was more profitable for investors over the last year : 8.17 vs. BARDX (-6.81). VGRLX (11.20) and BARDX (11.12) have equivalent 5 years return.
BARDXVGRLXBARDX / VGRLX
Total Expense Ratio0.490.12408%
Annual Report Gross Expense Ratio0.600.12500%
Fund Existence10 years14 years-
Gain YTD4.07410.79038%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets223M3.57B6%
Annual Yield % from dividends2.614.7455%
Returns for 1 year-6.818.17-83%
Returns for 3 years-12.102.58-468%
Returns for 5 years11.1211.2099%
Returns for 10 yearsN/A3.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCUL7.450.40
+5.67%
Ocular Therapeutix
OGN9.020.26
+2.97%
Organon & Co
ANVS1.600.02
+1.27%
Annovis Bio
LHX218.390.39
+0.18%
L3Harris Technologies
FDBC41.430.06
+0.15%
Fidelity D & D Bancorp